The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Acute Ketamine Infusion in Rat Does Not Affect In Vivo [ 11 C]ABP688 Binding to Metabotropic Glutamate Receptor Subtype 5
Open accessAbstract
Detecting changes in metabotropic glutamate receptor 5 (mGluR5) availability through molecular imaging with the positron emission tomography (PET) tracer [ 11 C]ABP688 is valuable for studying dysfunctional glutamate transmission associated with neuropsychiatric disorders. Using an infusion protocol in rats, we visualized the acute effect of subanesthetic doses of ketamine on mGluR5 in rat brain. Ketamine is an N-methyl-D-aspartate (NMDA) receptor antagonist known to increase glutamate release. Imaging was performed with a high-affinity PET ligand [ 11 C]ABP688, a negative allosteric modulator of mGluR5. Binding did not change significantly from baseline to ketamine in any region, thereby confirming previous literature with other NMDA receptor antagonists in rodents. Hence, in rats, we could not reproduce the findings in a human setup showing significant decreases in the [ 11 C]ABP688 binding after a ketamine bolus followed by ketamine infusion. Species differences may have contributed to the different findings in the present study of rats. In conclusion, we could not confirm in rats that endogenous glutamate increases by ketamine infusion are reflected in [ 11 C]ABP688 binding decreases as was previously shown for humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1. Experimental procedures. A, Mechanism of action for ketamine. GABA transmission of inhibitory neurons is disturbed, leading to increased glutamate release. B, Detail of the ionotropic NMDA receptor which is (i) ligand-gated requiring glutamate to bind with coactivation of D-serine or glycine and (ii) voltage-dependent through channel blocks by extracellular Zn2+ and Mg2+ ions. Ketamine is a noncompetitive antagonist by binding in the open channel and at an allosteric site. C, Ketamine was continuously infused during the scan. The final dose of 30 mg/kg is reached at the middle of the last frame from a 60-minute dynamic acquisition of [11C]ABP688. After the positron emission tomography scan, a computed tomography scan is taken for attenuation correction. NMDA indicates N-methyl-D-aspartate.](https://figures.cochat.ai/paper-figures/0814c70e2c0643ef9a1cc7977f9fe5e9/acute-ketamine-infusion-in-rat-does-not-affect-in-vivo-sup-11-sup-c-abp688-figure-1.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, Kosten and colleagues tried applying [11C]ABP688 in vivo PET in rats to confirm the findings in humans without success (Kosten et al., 2018).”
From A single subanaesthetic dose of the rapid-acting antidepressant S-ketamine raises presynaptic SV2A density in limbic regions of the Wistar Kyoto rat model of depression (2024) · cites this paper as Kosten et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Ketamine: 50 Years of Modulating the Mind
Li, L., & Vlisides, P. E. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00612 · Cited by 385
PHARMACOKINETICS AND ANALGESIC EFFECT OF KETAMINE IN MAN
CLEMENTS, J. A., & NIMMO, W. S. (1981) · British Journal of Anaesthesia · doi:10.1093/bja/53.1.27 · Cited by 322
Deschwanden, A., Karolewicz, B., Feyissa, A. M., Treyer, V., Ametamey, S. M., Johayem, A., Burger, C., Auberson, Y. P., Sovago, J., Stockmeier, C. A., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.09111607 · Cited by 278
Potential Neurotoxicity of Ketamine in the Developing Rat Brain
Zou, X., Patterson, T. A., Sadovova, N., Twaddle, N. C., Doerge, D. R., Zhang, X., Fu, X., Hanig, J. P., Paule, M. G., Slikker, W., et al. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfn270 · Cited by 217
Imaging glutamate in schizophrenia: review of findings and implications for drug discovery
Poels, E. M. P., Kegeles, L. S., Kantrowitz, J. T., Slifstein, M., Javitt, D. C., Lieberman, J. A., Abi-Dargham, A., & Girgis, R. R. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.136 · Cited by 205
Distribution in the Brain and Metabolism of Ketamine in the Rat after Intravenous Administration
Cohen, M. L., Chan, S.-L., Way, W. L., & Trevor, A. J. (1973) · Anesthesiology · doi:10.1097/00000542-197310000-00003 · Cited by 174
Esterlis, I., DellaGioia, N., Pietrzak, R. H., Matuskey, D., Nabulsi, N., Abdallah, C. G., Yang, J., Pittenger, C., Sanacora, G., Krystal, J. H., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.58 · Cited by 148
Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation
Duncan, G. E., Leipzig, J. N., Mailman, R. B., & Lieberman, J. A. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00926-3 · Cited by 131
Miyamoto, S., Leipzig, J. N., Lieberman, J. A., & Duncan, G. E. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00127-x · Cited by 114
Cited by
A Review of Molecular Imaging of Glutamate Receptors
Kim, J., Marton, J., Ametamey, S. M., & Cumming, P. D. (2020) · Molecules · doi:10.3390/molecules25204749 · Cited by 63
DeLorenzo, C., Sóvágó, J., Gardus, J. D., Xu, J., Yang, J., Behrje, R., Kumar, J. S. D., Devanand, D. P., Pelton, G. H., Mathis, C. A., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.189 · Cited by 50
Beaurain, M., Salabert, A., Ribeiro, M. J., Arlicot, N., Damier, P., Jeune, F. L., Démonet, J., & Payoux, P. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00268 · Cited by 26
de Bartolomeis, A., Avagliano, C., Vellucci, L., D’Ambrosio, L., Manchia, M., D’Urso, G., Buonaguro, E. F., & Iasevoli, F. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.08.019 · Cited by 19
A molecular perspective on mGluR5 regulation in the antidepressant effect of ketamine
Elmeseiny, O. S. A., & Müller, H. K. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107081 · Cited by 14
Metadata
- Authors
- Kosten, L., Verhaeghe, J., wyffels, L., Stroobants, S., & Staelens, S.
- Affiliations
- University of Antwerp (BE)
- Corresponding author
- Staelens, Steven
- Venue
- Molecular Imaging
- Publisher
- SAGE Publications
- Published
- 2018-01-01
- Volume
- 17
- Pages
- 1536012118788636-1536012118788636
- ISSN
- 1535-3508 (ISSN-L)
- 1536-0121
- PMC
- PMC6144515
- OpenAlex
- W2890858769
- Cited by
- 17
- References
- 34
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 1 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 1
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Molecular Imaging (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Lirias (submittedVersion, cc-by-nc)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Universiteit Antwerpen
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Keywords
- ketamine, metabotropic glutamate receptor 5, [11C]ABP688, positron emission tomography, receptor binding, NMDA receptor antagonists, glutamate release, negative allosteric modulators, species differences, rat brain
- MeSH terms
- Animals, Brain, Carbon Radioisotopes, Ketamine, Male, Oximes, Protein Binding, Pyridines, Rats, Sprague-Dawley, Positron-Emission Tomography, Receptor, Metabotropic Glutamate 5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acute Ketamine Infusion in Rat Does Not Affect In Vivo [ 11 C]ABP688 Binding to Metabotropic Glutamate Receptor Subtype 5. https://app.cochat.ai/papers/10.1177/1536012118788636
- The paper
- Kosten, L., Verhaeghe, J., wyffels, L., Stroobants, S., & Staelens, S. (2018). Acute Ketamine Infusion in Rat Does Not Affect In Vivo [ 11 C]ABP688 Binding to Metabotropic Glutamate Receptor Subtype 5. Molecular Imaging. https://doi.org/10.1177/1536012118788636
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.